South Korea · Delayed Price · Currency is KRW OCI Holdings Company Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw stable consolidated profit amid external volatility, with strong U.S. energy and chemical/materials performance offsetting losses from scheduled maintenance in polysilicon. U.S. policy and AI-driven power demand are expected to drive future growth.
Fiscal Year 2025
-
Q4 2025 saw a return to profitability with KRW 811 billion in revenue and improved operating income, driven by OCI TerraSus recovery. Full-year results were impacted by earlier shutdowns, but outlook remains positive with new business launches and strong U.S. solar demand.
-
Q3 2025 revenue rose 9% QOQ to KRW 845 billion, with operating losses narrowing. OCI TerraSus and OCI Enterprises drove recovery, while new investments in wafers and data centers target future growth. Financial structure remains stable.
-
Q2 saw an 18% revenue decline and an operating loss, with all major subsidiaries impacted by macroeconomic and U.S. policy headwinds. Strategic realignment is underway, and earnings are expected to improve in the second half as market demand recovers.
-
Q1 saw a return to profitability with KRW 947 billion in sales and improved subsidiary performance, except for chemicals. Polysilicon and U.S. solar businesses drove growth, but market uncertainty from tariffs and weak demand persists.
Fiscal Year 2024
-
Revenue rose 35% year-over-year due to consolidation, but operating profit fell 81% amid weak solar and urban development segments. Market and policy uncertainties weighed on results, but strategic investments and share buybacks aim to support future growth.
-
Q3 saw a sharp drop in operating income due to weak polysilicon demand and higher urban development costs. AD/CVD uncertainties and Chinese oversupply pressured sales, but future U.S. demand and solar project sales offer recovery prospects.
-
Q2 2024 saw revenue rise 9.8% sequentially to KRW 950 billion, but operating income fell 9.8% due to U.S. module and urban development underperformance. OCIM's strong Q2 was offset by market uncertainties and regulatory headwinds, with a cautious outlook for H2 2024.